Key Client Fiduciary Advisors LLC Acquires New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Key Client Fiduciary Advisors LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 429 shares of the healthcare conglomerate’s stock, valued at approximately $212,000.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.5 %

UNH stock opened at $486.50 on Friday. The company has a market cap of $447.77 billion, a PE ratio of 29.74, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The business has a 50-day simple moving average of $498.30 and a 200 day simple moving average of $502.61. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.26 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. TD Cowen reduced their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Bank of America reiterated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target on the stock in a report on Wednesday, June 5th. Finally, JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.